A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.
Request To Download Free Sample of This Strategic Report @ Driving Forces Behind Growth: The exponential growth of the North America medical implant market is propelled by several key drivers.
Request To Download Free Sample of This Strategic Report @ Driving Forces of Growth: The unprecedented growth of the medical implant market is propelled by several key factors. Firstly, the aging ...
Cortigent, Inc. (CRTG) expects to raise $15 million in an initial public offering (IPO) on Friday, February 14th, IPO Scoop reports. The company will be issuing 1,500,000 shares at $10.00 per share.
Abbott announced new four-year data showing the long-term and sustained relief that its proprietary BurstDR™ spinal cord stimulation (SCS) technology provides people with chronic pain, particularly ...
Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, is proud to announce the expansion of MR labeling for its Freedom® Peripheral Nerve ...
Neurostimulation provides a relatively novel mechanism for promoting tear production through activation of the underlying nerve pathways via mechanical, chemical, or electrical stimuli.
A live Q&A session with White will follow the presentation. Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.